Cicero Diagnostics is a women’s health care company founded in October 2014. It is dedicated to the advancement of clinical assays for endometriosis primarily in the area of infertility and pain. Its current testing platforms, under the brand ReceptivaDx™ and MyReceptiva™ include several biomarkers highly associated with inflammation on the uterine lining most often diagnosed as endometriosis. Our company has over 400 IVF centers from around the world using our services and is expanding into the OB space to provide similar testing for women looking for answers .